{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:15:17Z","timestamp":1792120517930,"version":"4.4.0"},"reference-count":89,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007380","name":"Fondation de l'avenir","doi-asserted-by":"publisher","award":["AP-RM-18024"],"award-info":[{"award-number":["AP-RM-18024"]}],"id":[{"id":"10.13039\/100007380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Chronic kidney disease (CKD) is a major public health concern that affects around 10 percent of the world\u2019s population. The severity of CKD is mainly due to the high prevalence of cardiovascular (CV) complications in this population. The aim of this review is to describe the arterial remodelling associated with CKD, to provide a quick overview of the mechanisms involved and to review the recent pharmacological approaches aimed at improving vascular health in CKD. CKD patients are exposed to metabolic and haemodynamic disorders that may affect the CV system. Large artery functional and geometric abnormalities have been well documented in CKD patients and are associated with an increase in arterial stiffness and a maladaptive remodelling. Uraemic toxins, such as indoxyl sulphate, p-cresyl sulphate, protein carbamylation and advanced glycation products, exert various effects on vascular smooth muscle cell functions. The low-grade inflammation associated with CKD may also affect arterial wall composition and remodelling. It is worth noting that the CV risk for CKD patients remains high despite the pharmacological control of traditional CV risk factors, suggesting the need for innovative therapeutic strategies. An interventional study targeting the NLRP3 inflammasome has provided some interesting preliminary results that need to be confirmed, especially in terms of safety.<\/jats:p>","DOI":"10.3390\/jcm10173803","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:19:26Z","timestamp":1629937166000},"page":"3803","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Arterial Remodelling in Chronic Kidney Disease: Impact of Uraemic Toxins and New Pharmacological Approaches"],"prefix":"10.3390","volume":"10","author":[{"given":"Nabil","family":"Foudi","sequence":"first","affiliation":[{"name":"INSERM, CNRS, MITOVASC, Equipe CarMe, SFR ICAT, Universit\u00e9 Angers, F-49000 Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeva","family":"Palayer","sequence":"additional","affiliation":[{"name":"INSERM, CNRS, MITOVASC, Equipe CarMe, SFR ICAT, Universit\u00e9 Angers, F-49000 Angers, France"},{"name":"Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire d\u2019Angers, F-49000 Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3738-5998","authenticated-orcid":false,"given":"Marie","family":"Briet","sequence":"additional","affiliation":[{"name":"INSERM, CNRS, MITOVASC, Equipe CarMe, SFR ICAT, Universit\u00e9 Angers, F-49000 Angers, France"},{"name":"Service de Pharmacologie-Toxicologie et Pharmacovigilance, Centre Hospitalo-Universitaire d\u2019Angers, F-49000 Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Garnier","sequence":"additional","affiliation":[{"name":"INSERM, CNRS, MITOVASC, Equipe CarMe, SFR ICAT, Universit\u00e9 Angers, F-49000 Angers, France"},{"name":"Service de N\u00e9phrologie-Dialyse-Transplantation, Centre Hospitalo-Universitaire d\u2019Angers, F-49000 Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Hill, N.R., Fatoba, S.T., Oke, J.L., Hirst, J.A., O\u2019Callaghan, C.A., Lasserson, D.S., and Richard Hobbs, F.D. (2016). Global Prevalence of Chronic Kidney Disease\u2014A Systematic Review and Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158765"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1681\/ASN.2015050542","article-title":"CKD Prevalence Varies across the European General Pop-ulation","volume":"27","author":"Stel","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_3","unstructured":"GBD (2016). Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388, 1459\u20131544."},{"key":"ref_4","unstructured":"(2021, August 18). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Available online: https:\/\/kdigo.org\/wp-content\/uploads\/2017\/02\/KDIGO_2012_CKD_GL.pdf."},{"key":"ref_5","unstructured":"GBD (2016). Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388, 1545\u20131602."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","article-title":"Chronic kidney disease: Global dimension and perspectives","volume":"382","author":"Jha","year":"2013","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1681\/ASN.2016050562","article-title":"Global Cardiovascular and Renal Outcomes of Reduced GFR","volume":"28","author":"Thomas","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am. J. Kidney Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Chronic Kidney Disease Prognosis Consortium (2010). Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet, 375, 2073\u20132081.","DOI":"10.1016\/S0140-6736(10)60674-5"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1742-1241.2012.02954.x","article-title":"Cardiovascular disease in chronic kidney disease: Untying the Gordian knot","volume":"67","author":"Hajhosseiny","year":"2012","journal-title":"Int. J. Clin. Pr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and car-diovascular risk: Epidemiology, mechanisms, and prevention","volume":"27","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: A meta-analysis","volume":"380","author":"Fox","year":"2012","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(12)61272-0","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: A meta-analysis","volume":"380","author":"Mahmoodi","year":"2012","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2004030203","article-title":"Chronic Kidney Disease and the Risk for Cardiovascular Disease, Renal Replacement, and Death in the United States Medicare Population, 1998 to 1999","volume":"16","author":"Foley","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_15","unstructured":"Bethesda, M.D., and National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (2007). USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jacc.2007.03.037","article-title":"The Framingham Predictive Instrument in Chronic Kidney Disease","volume":"50","author":"Weiner","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Jardine","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"EVOLVE Trial Investigators (2012). Effect of cinacalcet on car-diovascular disease in patients undergoing dialysis. N. Engl. J. Med., 367, 2482\u20132494.","DOI":"10.1056\/NEJMoa1205624"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"Akizawa","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ki.1990.19","article-title":"Aortic and large artery compliance in end-stage renal failure","volume":"37","author":"London","year":"1990","journal-title":"Kidney Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1161\/01.CIR.99.18.2434","article-title":"Impact of Aortic Stiffness on Survival in End-Stage Renal Disease","volume":"99","author":"Blacher","year":"1999","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/HYPERTENSIONAHA.113.01200","article-title":"Determinants of progression of aortic stiffness in hemodialysis patients: A prospective longitudinal study","volume":"62","author":"Utescu","year":"2013","journal-title":"Hypertension"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/j.ajkd.2004.11.011","article-title":"Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease","volume":"45","author":"Wang","year":"2005","journal-title":"Am. J. Kidney Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.ki.5000047","article-title":"Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease","volume":"69","author":"Briet","year":"2006","journal-title":"Kidney Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/HYPERTENSIONAHA.117.10648","article-title":"Association of Pulse Wave Velocity with Chronic Kidney Disease Progression and Mortality","volume":"71","author":"Townsend","year":"2018","journal-title":"Hypertension"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ajh.2009.240","article-title":"Aortic PWV in Chronic Kidney Disease: A CRIC Ancillary Study","volume":"23","author":"Townsend","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/CIRCHEARTFAILURE.113.001041","article-title":"Arterial Stiffness, Central Pressures, and Incident Hospitalized Heart Failure in the Chronic Renal Insufficiency Cohort Study","volume":"7","author":"Chirinos","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1681\/ASN.2010080863","article-title":"Arterial Remodeling Associates with CKD Progression","volume":"22","author":"Briet","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/HYPERTENSIONAHA.112.197210","article-title":"Large artery stiffening and remodeling are inde-pendently associated with all-cause mortality and cardiovascular events in chronic kidney disease","volume":"60","author":"Karras","year":"2012","journal-title":"Hypertension"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1161\/ATVBAHA.120.313131","article-title":"Arterial Stiffness: A Focus on Vascular Calcification and Its Link to Bone Mineralization","volume":"40","author":"Chen","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bone.2016.08.022","article-title":"Calcium as a cardiovascular toxin in CKD-MBD","volume":"100","author":"Moe","year":"2016","journal-title":"Bone"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1525-139X.2003.160301.x","article-title":"Calcium phosphate metabolism and cardiovascular disease in patients with chronic kidney disease","volume":"16","author":"Block","year":"2003","journal-title":"Semin Dial."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2215\/CJN.02910707","article-title":"Contribution of Bone and Mineral Abnormalities to Cardiovascular Disease in Patients with Chronic Kidney Disease","volume":"3","author":"Raggi","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: Classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Vanholder, R., Pletinck, A., Schepers, E., and Glorieux, G.L. (2018). Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update. Toxins, 10.","DOI":"10.3390\/toxins10010033"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.ajkd.2016.10.033","article-title":"Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients","volume":"70","author":"Shafi","year":"2017","journal-title":"Am. J. Kidney Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.metabol.2016.05.009","article-title":"Serum uric acid and mortality in chronic kidney disease: A systematic review and meta-analysis","volume":"65","author":"Xia","year":"2016","journal-title":"Metabolism"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1681\/ASN.2012030254","article-title":"Protein Carbamylation Predicts Mortality in ESRD","volume":"24","author":"Koeth","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"c237","DOI":"10.1159\/000320193","article-title":"?2-Microglobulin, Pulse Pressure and Metabolic Alterations in Hemodialysis Patients","volume":"117","author":"Raikou","year":"2011","journal-title":"Nephron Clin. Pr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/cphy.c100039","article-title":"Physiology of Endothelin and the Kidney","volume":"1","author":"Kohan","year":"2011","journal-title":"Compr. Physiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000328704","article-title":"Endothelin Antagonism in Patients with Nondiabetic Chronic Kidney Disease","volume":"172","author":"Dhaun","year":"2011","journal-title":"Contrib. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1681\/ASN.2014101047","article-title":"Uremic Toxicity of Advanced Glycation End Products in CKD","volume":"27","author":"Stinghen","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.atherosclerosis.2008.08.014","article-title":"The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease","volume":"204","author":"Pawlak","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fphys.2018.00089","article-title":"Phenotypic Modulation of Cultured Primary Human Aortic Vascular Smooth Muscle Cells by Uremic Serum","volume":"9","author":"Cidad","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jcp.24715","article-title":"Distinct Effects of Inorganic Phosphate on Cell Cycle and Apoptosis in Human Vascular Smooth Muscle Cells: Inorganic phosphate et smooth muscle cells","volume":"230","author":"Ourouda","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5935\/0101-2800.20160024","article-title":"p-cresol but not p-cresyl sulfate stimulate MCP-1 production via NF-\u03baB p65 in human vascular smooth muscle cells","volume":"38","author":"Maciel","year":"2016","journal-title":"J. Bras. Nefrol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2741\/4337","article-title":"Chronic kidney disease alters vascular smooth muscle cell phenotype","volume":"20","author":"Monroy","year":"2015","journal-title":"Front. Biosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1681\/ASN.2007121312","article-title":"CKD Accelerates Development of Neointimal Hyperplasia in Arteriovenous Fistulas","volume":"20","author":"Kokubo","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Rangrez, A.Y., M\u2019Baya-Moutoula, E., Meuth, V.M.-L., H\u00e9naut, L., Djelouat, M.S.E.I., Benchitrit, J., Massy, Z.A., and Metzinger, L. (2012). Inorganic Phosphate Accelerates the Migration of Vascular Smooth Muscle Cells: Evidence for the Involvement of miR. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047807"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/sj.ki.5000340","article-title":"Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells","volume":"69","author":"Yamamoto","year":"2006","journal-title":"Kidney Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.jrn.2008.10.014","article-title":"Indoxyl Sulfate Promotes Proliferation of Human Aortic Smooth Muscle Cells by Inducing Oxidative Stress","volume":"19","author":"Muteliefu","year":"2009","journal-title":"J. Ren. Nutr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1744-9987.2010.00885.x","article-title":"Uremic Toxin Indoxyl Sulfate Inhibits Human Vascular Smooth Muscle Cell Proliferation","volume":"15","author":"Mozar","year":"2011","journal-title":"Ther. Apher. Dial."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s11684-016-0463-x","article-title":"p-Cresyl sulfate promotes the formation of atherosclerotic lesions and induces plaque instability by targeting vascular smooth muscle cells","volume":"10","author":"Han","year":"2016","journal-title":"Front. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.lfs.2012.06.033","article-title":"Indoxyl sulfate enhances angiotensin II signaling through upregulation of epidermal growth factor receptor expression in vascular smooth muscle cells","volume":"91","author":"Shimizu","year":"2012","journal-title":"Life Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/ATVBAHA.110.216739","article-title":"Sirtuin 1 Retards Hyperphosphatemia-Induced Calcification of Vascular Smooth Muscle Cells","volume":"31","author":"Takemura","year":"2011","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mad.2015.10.001","article-title":"Hyperphosphatemia induces cellular senescence in human aorta smooth muscle cells through integrin linked kinase (ILK) up-regulation","volume":"152","author":"Troyano","year":"2015","journal-title":"Mech. Ageing Dev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"C126","DOI":"10.1152\/ajpcell.00329.2011","article-title":"Indoxyl sulfate promotes vascular smooth muscle cell senescence with upregulation of p53, p21, and prelamin A through oxidative stress","volume":"303","author":"Muteliefu","year":"2012","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/jemt.23369","article-title":"Indoxyl sulfate-induced calcification of vascular smooth muscle cells via the PI3K\/Akt\/NF-\u03baB signaling pathway","volume":"82","author":"He","year":"2019","journal-title":"Microsc. Res. Tech."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/cclm-2012-0880","article-title":"Post-translational modification derived products (PTMDPs): Toxins in chronic diseases?","volume":"52","author":"Gillery","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1681\/ASN.2010040365","article-title":"Chronic uremia stimulates LDL carbamylation and atheroscle-rosis","volume":"21","author":"Apostolov","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/ki.2014.218","article-title":"The urea decomposition product cyanate promotes endothelial dysfunction","volume":"86","author":"Rao","year":"2014","journal-title":"Kidney Int."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.18632\/aging.102002","article-title":"Proteasome-dependent degradation of intracellular carbamylated proteins","volume":"11","author":"Desmons","year":"2019","journal-title":"Aging"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3747\/pdi.2013.00338","article-title":"Serum and Tissue Accumulation of Advanced Glycation End-Products Correlates with Vascular Changes","volume":"35","author":"Hocine","year":"2015","journal-title":"Perit. Dial. Int."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.metabol.2008.05.016","article-title":"Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease","volume":"57","author":"Ueno","year":"2008","journal-title":"Metabolism"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1525-1594.2009.00801.x","article-title":"Association of Serum Pentosidine With Arterial Stiffness in Hemodialysis Patients","volume":"34","author":"Zhou","year":"2010","journal-title":"Artif. Organs"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1006\/bbrc.1997.7424","article-title":"Advanced Glycation Endproducts Stimulate Mitogen-Activated Protein Kinase and Proliferation in Rabbit Vascular Smooth Muscle Cells","volume":"239","author":"Satoh","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mvr.2017.02.004","article-title":"Effect of crocetin on vascular smooth muscle cells migration induced by advanced glycosylation end products","volume":"112","author":"Xiang","year":"2017","journal-title":"Microvasc. Res."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Koike, S., Yano, S., Tanaka, S., Sheikh, A.M., Nagai, A., and Sugimoto, T. (2016). Advanced Glycation End-Products Induce Apoptosis of Vascular Smooth Muscle Cells: A Mechanism for Vascular Calcification. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091567"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00004872-200301000-00002","article-title":"Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes","volume":"21","author":"Aronson","year":"2003","journal-title":"J. Hypertens."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ki.2009.503","article-title":"Plasma interleukin-6 is independently associ-ated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease","volume":"77","author":"Barreto","year":"2010","journal-title":"Kidney Int."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.krcp.2013.08.001","article-title":"Proinflammatory CD14(+)CD16(+) monocytes are associated with vas-cular stiffness in predialysis patients with chronic kidney disease","volume":"32","author":"Lee","year":"2013","journal-title":"Kidney Res. Clin. Pract."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2010.03.025","article-title":"Angiotensin II type 1 receptor blockers prevent tumor necrosis factor-\u03b1-mediated endothelial nitric oxide synthase reduction and superoxide production in human umbilical vein endothelial cells","volume":"636","author":"Kataoka","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1681\/ASN.2019020117","article-title":"Arterial Stiffness in the Heart Disease of CKD","volume":"30","author":"Zanoli","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jash.2017.09.013","article-title":"Association of interleukin-6 with aortic stiffness in end-stage renal disease","volume":"12","author":"Desjardins","year":"2018","journal-title":"J. Am. Soc. Hypertens."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/HJH.0b013e32836569c7","article-title":"Relationship between aortic pulse wave velocity, selected proinflammatory cytokines, and vascular calcification parameters in peritoneal dialysis patients","volume":"32","author":"Krzanowski","year":"2014","journal-title":"J. Hypertens."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10067-017-3657-y","article-title":"The effect of TNF-a antagonists on aortic stiffness and wave reflections: A meta-analysis","volume":"37","author":"Vlachopoulos","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000490396","article-title":"CXCL12 in Patients with Chronic Kidney Disease and Healthy Controls: Relationships to Ambulatory 24-Hour Blood Pressure and Echocardiographic Measures","volume":"8","author":"Pilecki","year":"2018","journal-title":"Cardiorenal Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/eurheartj\/eht481","article-title":"Higher plasma CXCL12 levels predict incident myocardial infarction and death in chronic kidney disease: Findings from the Chronic Renal Insufficiency Cohort study","volume":"35","author":"Mehta","year":"2014","journal-title":"Eur. Hear. J."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.vph.2011.11.008","article-title":"Salvianolic acid B inhibits SDF-1\u03b1-stimulated cell proliferation and migration of vascular smooth muscle cells by suppressing CXCR4 receptor","volume":"56","author":"Pan","year":"2012","journal-title":"Vasc. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","article-title":"Inflammasomes in health and disease","volume":"481","author":"Strowig","year":"2012","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1523-1755.1998.00981.x","article-title":"Immunologic function and survival in hemo-dialysis patients","volume":"54","author":"Kimmel","year":"1998","journal-title":"Kidney Int."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"882","DOI":"10.4049\/jimmunol.154.2.882","article-title":"Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes","volume":"154","author":"Herbelin","year":"1995","journal-title":"J. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1159\/000486061","article-title":"NLRP3 Gene Deletion Attenuates Angiotensin II-Induced Phenotypic Transformation of Vascular Smooth Muscle Cells and Vascular Remodeling","volume":"44","author":"Ren","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e3074","DOI":"10.1038\/cddis.2017.470","article-title":"NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension","volume":"8","author":"Sun","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): A randomised pla-cebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2017.12.007","article-title":"Management of Traditional Cardiovascular Risk Factors in CKD: What Are the Data?","volume":"72","author":"Gregg","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1681\/ASN.2016040453","article-title":"IL-1 Inhibition and Vascular Function in CKD","volume":"28","author":"Nowak","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1681\/ASN.2010070760","article-title":"IL-1\u03b2 Receptor Antagonist Reduces Inflammation in Hemodialysis Patients","volume":"22","author":"Hung","year":"2011","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/17\/3803\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:51:28Z","timestamp":1760165488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/17\/3803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":89,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["jcm10173803"],"URL":"https:\/\/doi.org\/10.3390\/jcm10173803","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,25]]}}}